ישראל - עברית - Ministry of Health

romat ltd - aspartic acid; cyanocobalamin; d, l-acetylmethionine; fructose; glutamic acid; glycine; l- citrulline; l- lysine as hydrochloride; l- ornithine as hydrochloride; l-arginine; l-carnitine as hydrochloride; pyridoxine (vit b6) hydrochloride; sorbitol; thioctic acid - תמיסה להזרקה - thioctic acid 0.2 mg/ml; cyanocobalamin 0.03 mg/ml; glycine 1.5 mg/ml; aspartic acid 1.5 mg/ml; glutamic acid 1.5 mg/ml; fructose 50 mg/ml; sorbitol 80 mg/ml; pyridoxine (vit b6) hydrochloride 0.15 mg/ml; l- ornithine as hydrochloride 1.20 mg/ml; l- lysine as hydrochloride 0.50 mg/ml; l- citrulline 1.20 mg/ml; l-carnitine as hydrochloride 5.00 mg/ml; l-arginine 2.40 mg/ml; d, l-acetylmethionine 20.00 mg/ml

ישראל - עברית - Ministry of Health

a.veterinary supply ltd - acepromazine maleate 10 mg/ml - solution for injection - dogs and cats: promace can be used as an aid in controlling intractible animals during examination treatment grooming x-ray and minor surgical procedures to alleviate itching as a result of skin irritation as an antiemetic to control vomiting associated with motion sickness. promace is particularly useful as a preanesthetic agent (1) to enhance and prolong the effects of barbiturates thus reducing the requirements for general anesthesia (2) as an adjunct to surgery under local anesthesia. horses: promace can be used as an aid in controlling fractious animals during examination treatment loading and transportation. particularly useful when used in conjunction with local anesthesia for firing castration neurectomy removal of skin tumors ocular surgery and applying casts.

ישראל - עברית - Ministry of Health

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 250 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a .fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

ישראל - עברית - Ministry of Health

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 500 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

ישראל - עברית - Ministry of Health

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 1000 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה להכנת תמיסה לזריקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 100 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ישראל - עברית - Ministry of Health

medici medical ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 1500 iu/dose - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.